Effective treatment of canine chronic cutaneous lupus erythematosus variants with oclacitinib: Seven cases

BACKGROUND: The treatment of canine chronic cutaneous lupus erythematosus (CCLE) variants generally requires immunosuppression, which often results in potentially severe adverse effects. Janus kinase inhibitors, like oclacitinib, might be a valuable treatment option due to their rapid inhibition of...

Descripción completa

Detalles Bibliográficos
Autores principales: Harvey, Richard G., Olivrī, Alla, Lima, Tatiana, Olivry, Thierry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Auto‐immune and Immune‐Mediated Dermatoses
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092348/
https://www.ncbi.nlm.nih.gov/pubmed/36229964
http://dx.doi.org/10.1111/vde.13128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092348/
https://www.ncbi.nlm.nih.gov/pubmed/36229964
http://dx.doi.org/10.1111/vde.13128

Ejemplares similares